Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: arthritis treatment + arthritis + treatment  Related to the article below (Last Update: 8/4/2008)

Behavioral Comorbidities in Rheumatoid Arthritis
Psychiatric Times, NY -
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum. 1993;36:1681-1690. 16. ...

ChattahBox
FDA Advisory Committee Recommends Approval of ACTEMRA(R ...
MarketWatch - Jul 29, 2008
NUTLEY, NJ, July 29, 2008 /PRNewswire via COMTEX/ -- Roche today announced that the Arthritis Advisory Committee of the US Food and Drug Administration ...
FDA Advisory Committee Recommends Approval Of Actemra For The ... Medical News Today (press release)
2nd UPDATE: FDA Panel Backs Roche Athritis Drug Actemra CNNMoney.com
FDA Panel Backs Rheumatoid-Arthritis Drug Wall Street Journal
The Associated Press - Ortho SuperSite
all 147 news articles »  OTC:RHHBY - SWF:RO - SWF:HUE

HealthNews
Old World Frankincense Offers Hope for Arthritis
HealthNews, CA - Aug 3, 2008
The typical treatment for OA is some form of non-steroidal anti-inflammatory drug (NSAID) to reduce the swelling, but they come with many adverse side ...
Indian herb hope for arthritis relief Calcutta Telegraph
Frankincense 'can ease arthritis' BBC News
5-LOXIN(R) Proven to Reduce the Symptoms of Osteoarthritis in New ... MarketWatch
TopNews - PRESS TV
all 67 news articles »
One In 7 Utahns Struggle With Arthritis
eMaxHealth.com, NC -
?The study is important because we tend to get treatment for a single condition and rarely focus on the issue of multiple diseases,? says Arthritis Program ...
Candidates for gastric banding are very carefully selected, one ...
Irish Times, Ireland -
We are generally dealing with patients who, along with obesity, have other problems such as diabetes, high blood pressure, heart disease and arthritis. ...
When health problems are skin deep
Chester DailyLocal.com,  USA -
"About 20 to 30 percent of patients with psoriasis will also have psoriatic arthritis," said Gottlieb. "Sometimes it can be quite severe and disabling. ...
*ROCHE: FDA COMMITTEE RECOMMENDS ACTEMRA FOR TREATMENT OF ...
華富財經, Hong Kong - Jul 29, 2008
In relation to the stock quote service (the "Quote Service") information, the stock price, trade volume and turnover are provided by The Stock Exchange of ...
GlaxoSmithKline and Genmab: Breakthrough in Leukemia Treatment
TopNews, India -
The two companies are even eager and trying hard to use the human antibody, ofatumumab, for treating various types of lymphoma, rheumatoid arthritis as well ...GSK - CPH:GEN

Daily Mail
Doctor, I've got a bone to pick with you... The bone problems that ...
Daily Mail, UK -
Meanwhile, a recent study by the University of Derby has highlighted shortfalls in treatment for those with osteoporosis, finding that as few as one in ...

BBC News
Drug restriction 'hits patients'
BBC News, UK -
However, for some patients - such as those with chronic back pain, arthritis, or sciatica - coproxamol was the most effective drug available. ...
Source: Google News

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis -
PE Lipsky, DMFM van der Heijde, EW St Clair, DE … - New England Journal of Medicine, 2000 - content.nejm.org
... Treatment of rheumatoid arthritis. ... Risks of solid cancers in patients with rheumatoid
arthritis and after treatment with tumour necrosis factor antagonists. ...

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc … -
LW Moreland, SW Baumgartner, MH Schiff, EA Tindall … - New England Journal of Medicine, 1997 - content.nejm.org
... Increased peripheral T cell reactivity to microbial antigens and collagen type II
in rheumatoid arthritis after treatment with soluble TNF{alpha} receptors. ...

… of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis -
C Bombardier, L Laine, A Reicin, D Shapiro, R … - New England Journal of Medicine, 2000 - content.nejm.org
... Conclusions In patients with rheumatoid arthritis, treatment with rofecoxib, a
selective inhibitor of cyclooxygenase-2, is associated with significantly fewer ...

Arthritis of the Hip after Dislocation and Acetabular Fractures: Treatment by Mold Arthroplasty: AN … -
WH HARRIS - The Journal of Bone and Joint Surgery, 1969 - JBJS
... STUDY USING A NEW METHOD OF RESULT EVALUATION Fractures: Treatment by Mold Arthroplasty:
AN END-RESULT Traumatic Arthritis of the Hip after Dislocation and ...

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial -
PJ Mease, BS Goffe, J Metz, A VanderStoep, B Finck … - The Lancet, 2000 - Elsevier
... All rights reserved. Articles. Etanercept in the treatment of psoriatic
arthritis and psoriasis: a randomised trial. Philip J Mease ...

[CITATION] … Arthritis of the Hip after Dislocation and Acetabular Fractures: Treatment by Mold Arthroplasty
HYWII HAKKIS, B MDf - The Journal of Bone and Joint Surgery
-

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist -
B Bresnihan, JM Alvaro-Gracia, M Cobby, M Doherty, … - Arthritis & Rheumatism, 1998 - doi.wiley.com
... American College ol Rheumatvlvgy TREATMENT OF RHEUMATOID ARTHRITIS WITH
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST BARRY ...

Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or … -
JR O'Dell, CE Haire, N Erikson, W Drymalski, W … - New England Journal of Medicine, 1996 - content.nejm.org
... Progress in the Treatment of Rheumatoid Arthritis. ... A new era in rheumatoid arthritis
treatment--time to introduce a modified treatment pyramid. ...

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha … -
MJ Elliott, RN Maini, M Feldmann, A Long-Fox, P … - Arthritis Rheum, 1993 - ncbi.nlm.nih.gov
Comment in: Arthritis Rheum. 1998 Mar;41(3):564-5. Treatment of rheumatoid arthritis
with chimeric monoclonal antibodies to tumor necrosis factor alpha. ...

… alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant … -
R Maini, EW StClair, F Breedveld, D Furst, J … - Lancet, 1999 - informedpharmacotherapy.com
... Patients were included in the study if they had active rheumatoid arthritis despite
treatment with oral or parenteral methotrexate at a stable dose of at least ...

Source: Google Scholar
 
 

Trial Results Will Help In Treatment Of Arthritis

Article Date: 14 Nov 2006 - 2:00am (PST)
Rates of heart attack, stroke or death in patients with arthritis on the COX-2 inhibitor etoricoxib are similar to those in patients on the NSAID* diclofenac, according to an Online/Article published November 13, 2006 by The Lancet. However, the drugs, which are both types of painkiller, were found to have different rates of other side-effects. This information will help doctors choose the best treatment for their patients, state the authors.

NSAIDs are often taken long term by arthritis patients. However, they can cause gastrointestinal (GI) bleeding and some studies have suggested that traditional NSAIDs, like diclofenac, can also increase cardiovascular** risk. COX-2 inhibitors reduce GI bleeding but they may increase the risk of cardiovascular events. The safety data for these drugs therefore raise concerns for patients with arthritis requiring long term treatment.

In the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) trial, Christopher Cannon (Brigham and Women's Hospital, Boston, MA, USA) and colleagues present the primary results of a randomised comparison of etoricoxib and diclofenac, involving patients with osteoarthritis or rheumatoid arthritis from 46 countries. In the study, 34 701 participants were randomly assigned to etoricoxib (60mg or 90 mg daily) or diclofenac (150mg daily) for an average of 18 months. The researchers found that the rate of adverse thrombotic cardiovascular events was similar for both treatment groups. They also found that the overall rate of upper GI events (ulcers, bleeding) was lower in patients taking etoricoxib, but the rate of life-threatening upper GI events were the same for both medications. Congestive heart failure was rare, but more common in the 90 mg etoricoxib group and more patients discontinued this drug dose due to swelling of the ankles. Both doses of etoricoxib had higher rates of discontinuation due to high blood pressure. Patients on diclofenac had higher rates of discontinuation due to adverse GI and liver events. Both drugs were similar in their effectiveness.

Article continues below and (thank you)

 

Dr Cannon concludes: "In clinical practice, the choice of anti-inflammatory agent needs to take into consideration the risk for thrombotic cardiovascular and gastrointestinal events, as well as congestive heart failure and other renovascular effects (eg, blood pressure, fluid retention), gastrointestinal tolerability (eg, dyspepsia), and efficacy. The data from this large randomised clinical trial should help clinicians and patients, and will hopefully encourage guideline committees to develop recommendations for optimum treatment of patients with arthritis."

###

*NSAID - non-steroidal anti-inflammatory drug **Cardiovascular disease - class of diseases that involve the heart and/or blood vessels

The MEDAL results were presented at the late-breaking clinical trial session at the American Heart association's (AHA) Scientific Sessions on November 13, 2006.

Contact: Joe Santangelo
Lancet

 

 

Depression treatment helps arthritis
Main Category: Depression News
Article Date: 12 Nov 2003 - 0:00 PST

Treating elderly patients for depression can help ease arthritis pain, an unexpected and hopeful finding for sufferers of the degenerative joint disease, the author of a study released on Tuesday said.

Depression affects roughly one in six older Americans, while four out of five suffer degenerative joint disease after age 70, according to the study in the newest issue of The Journal of the American Medical Association.

Older people treated for depression with medication and therapy not only showed fewer symptoms of that depression after a year, but their arthritis symptoms eased as well, the study showed.

They had less pain and less interference with daily activities due to arthritis, it showed.

'This was a very interesting, somewhat unexpected benefit of depression treatment. This was not something that we knew we would find,' said Dr. Elizabeth Lin, the study's lead author.

Given there is no known cure for arthritis, 'it was nice, encouraging news,' she said. 'We were just so delighted to see improvement in the arthritis area.'

The study is the first to look at the effect of depression treatment on arthritis, she said. It included 1,801 depressed adults over age 60 in five states from July 1999 to August 2001.

 

 

Chiropractic For Arthritis - Benefits, Concerns, Side Effects, And Effectiveness
Main Category: Arthritis News
Article Date: 23 Nov 2006 - 14:00 PST
|


The word ARTHRITIS means inflammation of the joint. Arthritis can affect a person at any age. Sometimes the symptoms of arthritis are called rheumatism. Eight classes of arthritis and related conditions have been identified. These are:

Inflammatory - the membrane of the joint becomes irritated

Attachment Arthritis - frequently in the heels and lower back, the ligament or tendon fastened to the bone becomes irritated

Crystal Arthritis - the big toe has deposits of microscopic crystals of sodium urate

Joint Infection - bacteria contaminate the fluid inside the joint, usually found in the hip, shoulder and knee

Cartilage Degeneration - usually found in the knees, neck, lower back, hips and fingers, this type of arthritis arises when the cartilage of the joint breaks down

Muscle Inflammation - muscle tissue becomes inflamed

Local Conditions - a local injury causes pain, such as tennis elbow

General Conditions - a condition characterized by generalized muscle pain and sleep disturbance.

Chiropractic is a remedial system that centers on the structure of the body. Daniel David Palmer gave the first chiropractic treatment in 1895. He derived the name chiropractic from the Greek CHEIR meaning hand, and PRAKTIKOS meaning practice or perform. Treatment is adapted to suit the age, build, pain levels and general health of the individual. Treatment schedules depend on whether your problem is acute or chronic, and on your age and general health.

The chiropractic treatment for arthritis depends on whether the practitioner is a straight or mixed chiropractor. The body is permitted to cure itself by straight chiropractors, who treat arthritis by working with the spine to correct subluxation and other imbalances. The mixed chiropractor will probably treat arthritis and other remedies such as acpupressure mixed with manipulation.

X-rays of many people in their 20's show that arthritis is not just an old age thing. Chiropractor Dr. Lynn Kelly has identified the number one cause of arthritis as being joints that aren't moving properly because of misalignments of the bones that form them. Your spine is a group of cylinder-shaped bones with knobs on the backs and side of each bone that fit into grooves in the neighboring vertebra, and a chiropractor can evaluate these joints for you.

Chiropractic adjustments are painless for most patients. Tiny pockets of gas are relieved from the joints when your vertebrae are adjusted, making a "popping" noise. Dozens of research studies have recognized the safety and helpfulness of chiropractic care. Chiropractors are also taught to identify when damage is outside of their scope of practice and will refer patients to the proper medical specialist if needed.

The small joints of the body can be damaged by rheumatoid arthritis, as with any joint in the body. One in five to one in three patients with RA have spinal involvement. If you're an RA patient with spinal involvement, you should not have chiropractic manipulation done, as it can cause your spinal instability to worsen.

by: Adam O'Connor

www.backhealthpro.com


 

Rheumatoid Arthritis Treatment With Methotrexate Effective The Second Time
Main Category: Arthritis News
Article Date: 27 Feb 2006 - 5:00 PST

A second course of methotrexate, the most commonly used drug to treat rheumatoid arthritis, is effective in nearly half of studied patients for whom a previous treatment with the drug was ineffective. These are the results of a study published today in Arthritis Research & Therapy, which also shows that a second treatment with methotrexate is particularly effective in patients who were given low dose methotrexate in their first treatment.

Theresa Kapral and colleagues from the Medical University of Vienna, Austria recruited patients with rheumatoid arthritis who had had at least two treatments with an anti-arthritis drug.

Kapral et al. identified 79 patients who had had a second methotrexate treatment lasting at least a year. The patients had terminated the first treatment either because it was ineffective or because of adverse events. Forty-two (53.2%) patients had an effective second treatment. The second treatment was effective in 23 (45.1%) of the patients who had stopped treatment because of inefficacy. Sixteen (66.7%) of the patients who had initially stopped treatment because of adverse events had a successful second treatment. The second treatment was more than twice as likely to be successful if the methotrexate dose in the first treatment had been low (lower or equal to 10mg per week) than if it had been high (greater than 17.5mg per week). There was no difference in efficacy between first and second treatment for other anti-arthritis drugs.

Physicians treating rheumatoid arthritis are in need of therapeutic options especially for patients with a history of repeated drug failures. The results of this study indicate that renewed institution of methotrexate might be one option that could be considered for the treatment of these patients.

###

Article:
Methotrexate Reemployment in Rheumatoid Arthritis is Frequently Effective Despite Its Earlier Failure Theresa Kapral, Tanja Stamm, Klaus P Machold, Karin Montag, Josef S Smolen and Daniel Aletaha Arthritis Research and Therapy 2006, 8: R46 (doi:10.1186/ar1902)

Contact: Juliette Savin
juliette.savin@biomedcentral.com
BioMed Central

 

Memories: It's All In The Packaging, Scientists Say


Researchers at UC Irvine have found that how much detail one remembers of an event depends on whether a certain portion of the brain is activated to "package" the memory.

The research may help to explain why sometimes people only recall parts of an experience such as a car accident, and yet vividly recall all of the details of a similar experience.

In experiments using functional magnetic resonance imaging (fMRI), the scientists were able to view what happened in the brains of subjects when they experienced an event made up of multiple contextual details. They found that participants who later remembered all aspects of the experience, including the details, used a particular part of the brain that bound the different details together as a package at the time the event occurred. When this brain region wasn't activated to bind together the details, only some aspects of an event were recalled. The findings appear in the current issue of Neuron.

"This study provides a neurological basis for what psychologists have been telling us for years," said Michael Rugg, director of UCI's Center for the Neurobiology of Learning and Memory and senior author of the paper. "You can't get out of memory what you didn't put into it. It is not possible to remember things later if you didn't pay attention to them in the first place."

The scientists presented 23 research subjects with a list of words while they underwent an fMRI scan. The words were in different colors and would appear in one of four quadrants on a screen. The subjects had to decide whether the words represented an animate or inanimate object. Later, the participants were presented the words again, interspersed with words they had not seen before, and asked if they remembered seeing those words before. They were also asked if they remembered in what color the word had originally been and in which of the four quadrants it had originally appeared.

If the participant could later remember the color of the word, a particular area of the brain associated with color processing was especially active during learning. If the subject later remembered the location of the word, activity was seen in an area associated with spatial processing. But if the subject remembered the word, the color and the location, then another critical brain region became involved. The researchers observed enhanced activity in the intra-parietal sulcus, a part of the parietal cortex. It appears that this region is responsible for binding together all the features of a particular memory so that contextual details, as well as more central aspects of the event such as the identity of the word, can later be recalled.

"We know that if the intra-parietal sulcus is damaged, then someone cannot attend to multiple aspects of the same object, such as its size and color," said Melina Uncapher, a graduate student researcher and lead author of the study. "This study provides empirical evidence for how critical this region is for bringing the constituents of a memory together in the brain.

"Memory is more than a sum of its parts. A complete memory of an event requires that the features of the event be brought together and processed by the brain as a common perceptual representation, before being stored."

###

Leun Otten of University College London collaborated on the study. The research was funded by the National Institute of Mental Health and the Wellcome Trust.

About the University of California, Irvine: The University of California, Irvine is a top-ranked university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 24,000 undergraduate and graduate students and about 1,400 faculty members. The second-largest employer in dynamic Orange County, UCI contributes an annual economic impact of $3.3 billion.

Contact: Farnaz Khadem
University of California - Irvine
 
Google
Web www.iconocast.com